Acute kidney injury is linked to higher mortality in elderly hospitalized patients with non-valvular atrial fibrillation.


Journal

Aging clinical and experimental research
ISSN: 1720-8319
Titre abrégé: Aging Clin Exp Res
Pays: Germany
ID NLM: 101132995

Informations de publication

Date de publication:
Apr 2019
Historique:
received: 07 02 2018
accepted: 06 07 2018
pubmed: 19 7 2018
medline: 9 5 2019
entrez: 19 7 2018
Statut: ppublish

Résumé

Renal insufficiency is associated with medical complications in patients with non-valvular atrial fibrillation (NVAF). However, data for elderly patients are scarce. Thus, the main objectives of the present study were to analyze the characteristics of elderly patients with NVAF and acute or chronic renal disease, describe their management in real-life conditions, and detect factors associated with complications. The NONAVASC registry includes patients > 75 years with NVAF, hospitalized by any cause in 64 Spanish Internal Medicine departments. Patients were categorized into acute kidney injury (AKI), chronic kidney disease (CKD) or preserved renal function (PRF). All variables associated with in-hospital mortality with P < 0.10 in univariate analysis were included to develop a multivariate logistic-regression model. The study included 804 patients (53.9% women), 352 (43.8%) of whom met diagnostic criteria for CKD. AKI was detected in 119 (14.8%) patients. AKI was associated with greater length of stay, higher mortality and an increased rate of patient transfer to nursing homes. After logistic-regression analysis, we found an association between mortality and AKI (OR 2.4, 95% CI 1.03-5.53; P = 0.045). The increase in creatinine values (OR 1.8, 95% CI 1.19-2.73; P = 0.005) and the decrease in albumin values (OR 2.0, 95% CI 1.05-3.73; P = 0.033) were also linked to mortality. Our study shows the relationship between AKI and creatinine value increase and a higher mortality in elderly patients with NVAF. In light of our findings, the detection of renal function impairment in these patients should alert physicians and consider them as high-risk patients.

Identifiants

pubmed: 30019264
doi: 10.1007/s40520-018-1001-2
pii: 10.1007/s40520-018-1001-2
doi:

Substances chimiques

Creatinine AYI8EX34EU

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

455-461

Auteurs

Ignacio Novo-Veleiro (I)

Internal Medicine Department, University Hospital of Santiago de Compostela, 15701, A Coruña, Spain. ignacio.novo.veleiro@gmail.com.

Antonio Pose-Reino (A)

Internal Medicine Department, University Hospital of Santiago de Compostela, 15701, A Coruña, Spain.

Alejandra Gullón (A)

Internal Medicine Department, University Hospital of La Princesa, Madrid, Spain.

Jesús Díez-Manglano (J)

Internal Medicine Department, University Hospital Miguel Servet, Zaragoza, Spain.

José-María Cepeda (JM)

Internal Medicine Department, Vega Baja Hospital, Orihuela, Alicante, Spain.

Francesc Formiga (F)

Geriatric Unit, Internal Medicine Department, L'Hospitalet de Llobregat, University Hospital of Bellvitge, Barcelona, Spain.

Miguel Camafort (M)

Internal Medicine Department, Clinic University Hospital, Barcelona, Spain.

José-María Mostaza (JM)

Internal Medicine Department, University Hospital of La Paz-Carlos III, Madrid, Spain.

Carmen Suárez (C)

Internal Medicine Department, University Hospital of La Princesa, Madrid, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH